Correlation Between Dynavax Technologies and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and Aquestive Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and Aquestive Therapeutics.
Diversification Opportunities for Dynavax Technologies and Aquestive Therapeutics
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dynavax and Aquestive is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between Dynavax Technologies and Aquestive Therapeutics
Given the investment horizon of 90 days Dynavax Technologies is expected to generate 0.5 times more return on investment than Aquestive Therapeutics. However, Dynavax Technologies is 2.0 times less risky than Aquestive Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 1,088 in Dynavax Technologies on November 2, 2024 and sell it today you would earn a total of 213.00 from holding Dynavax Technologies or generate 19.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dynavax Technologies vs. Aquestive Therapeutics
Performance |
| Timeline |
| Dynavax Technologies |
| Aquestive Therapeutics |
Dynavax Technologies and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dynavax Technologies and Aquestive Therapeutics
The main advantage of trading using opposite Dynavax Technologies and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.| Dynavax Technologies vs. Alkermes Plc | Dynavax Technologies vs. Neurocrine Biosciences | Dynavax Technologies vs. Intracellular Th | Dynavax Technologies vs. Aquestive Therapeutics |
| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |